CNS Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.
CNSP Key Statistics
Stock Snapshot
CNS Pharmaceuticals(CNSP) stock is priced at $2.41, giving the company a market capitalization of 1.53M. It carries a P/E multiple of -0.04.
On 2026-03-15, CNS Pharmaceuticals(CNSP) stock moved within a range of $2.32 to $2.83. With shares now at $2.41, the stock is trading +3.9% above its intraday low and -14.8% below the session's peak.
Trading activity shows a volume of 160.98K, compared to an average daily volume of 35.86K.
Over the past 52 weeks, CNS Pharmaceuticals(CNSP) stock has traded between a high of $55.20 and a low of $2.32.
Over the past 52 weeks, CNS Pharmaceuticals(CNSP) stock has traded between a high of $55.20 and a low of $2.32.
CNSP News
An update from CNS Pharmaceuticals ( (CNSP) ) is now available. On March 11, 2026, CNS Pharmaceuticals posted a new investor presentation outlining a strategic...
CNS Pharmaceuticals (CNSP) has launched a new corporate growth strategy designed to build a high-value pipeline in neurology and oncology. The strategy is being...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.